alexa Contribution Of ERK Nuclear Translocation To Cisplatin Resistance In Ovarian Cancer Cells
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th World Congress on Cancer Science & Therapy
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Shahana Dilruba, Anya Kalayda and Ulrich Jaehde
Posters: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.034
Abstract
The clinical use of the anti-cancer drug cisplatin is impaired by the development of resistance against this drug. However, the mechanisms of resistance are not completely understood yet. In this work, the importance of the subcellular localization of ERK1/2 (Extracellular Signal regulated Kinase1/2) for cisplatin resistance in ovarian cancer cells was examined. We studied both EFO27 and A2780 ovarian carcinoma cells and their corresponding cisplatin-resistant variants (EFO27/CDDP and A2780cis) for this purpose. Using MTT test and apoptosis assay (Annexin V-FITC using flow cytometry) we found that inhibition of ERK increased the sensitivity of cisplatin in EFO27 and EFO27/CDDP cells. However, opposite effect was found in A2780 cells. We also investigated translocation of ERK1/2 to nucleus in response to cisplatin by immunofluorescence. Translocation of ERK1/2 to nucleus in response to cisplatin was detected in EFO27 and EFO27/CDDP cells, but no such translocation was detected for A2780 and A2780cis cells. Further, PEA-15 (phosphoprotein enriched in astrocytes), a small protein which inhibits ERK1/2 translocation to nucleus, was used to investigate ERK cytoplasmic sequestration in cisplatin resistance. For this purpose, PEA- 15wt, PEA-15AA (nonphosphorylatable form) and PEA-15DD (phosphomimetic form) were overexpressed in A2780cis and EFO27/CDDP cell lines. The overexpression of PEA-15 and its mutated forms showed an increase in sensitivity of EFO27/ CDDP cells to cisplatin but a decreased sensitivity of A2780cis cells to cisplatin showing the importance of ERK1/2 localization for cisplatin sensitivity. Therefore, ERK1/2 nuclear translocation could be a good prognostic biomarker to determine cisplatin sensitivity in ovarian cancer as shown at cellular level.
Biography
Shahana Dilruba (S.D.) received her B.Sc. and M.Sc. degree in Biochemistry and Molecular Biology at Dhaka University. Afterwards, she performed a M.Sc. study in Molecular Biotechnology at the University of Bonn. Currently, she is working as a PhD student at the Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn under the supervision of Prof. Ulrich Jaehde. In her PhD work, she investigates the role of subcellular localization of activated ERK in cisplatin resistance in ovarian cancer cells. This PhD work is funded by Bonn International Graduate School (BIGS) and German Ministry of Education and Research (BMBF).
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

biochemjournals[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version